Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-06-27

FDA Approved: ELLA — Supplemental Application (HRA PHARMA AMERICA, INC.)

View source ↗

Summary

FDA approved a supplemental application for Ella (ulipristal acetate) submitted by HRA Pharma America, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ELLA (ULIPRISTAL ACETATE)

Snippet

SUPPL AP for ELLA (ULIPRISTAL ACETATE)